Originally established in 1999, Agilent Technologies emerged from Hewlett-Packard and has since become a prominent player in the life science and diagnostic sectors. With a focus on measurement technologies, Agilent serves a diverse customer base through its three main segments: life science and applied tools, cross lab (including consumables and services), and diagnostics and genomics. […]
Tag: advanced
AmphiStar & Kensing Partner for Upcycled Biosurfactants in NA Personal Care
AmphiStar and Kensing have teamed up to introduce upcycled biosurfactants to the North American personal care market. This strategic partnership combines AmphiStar’s innovative upcycled biosurfactant technology with Kensing’s industrial scale and market presence, ushering in a new era of high-performance biosurfactants. These biosurfactants, derived from upcycled biowaste, offer formulation versatility and competitive economics at scale […]
Enhanced Security Features in Android 16 Beta
The latest Android 16 beta introduces Advanced Protection, a one-click toggle that activates top-tier security settings to safeguard against known threats. This feature, highlighted in an APK teardown, restricts activities like sideloading and USB data access, providing a comprehensive security layer for users testing the QPR1 Beta 1 version. Once enabled, individual security settings cannot […]
Efficient Solutions with Advanced Manufacturing Technologies
Advanced manufacturing technologies offer efficient solutions for operational challenges. During start-up testing, a general engineer identified a potential issue with the proximity sensor on a Laser Measurement Gauge. By setting the distance between the laser and rotor as a safety measure, the technology prevents collisions and ensures smooth operation. This precision in-process control showcases the […]
Sun Pharma AR Suffers 20% Drop as Psoriasis Drug Fails Trials
Sun Pharma Advanced Research faces a 20% stock decline following the disappointment of SCD-044, an oral pill aimed at combating inflammatory skin conditions by targeting S1P receptor 1. This receptor is crucial in regulating immune cell movement, and the drug was anticipated to alleviate disease severity by influencing lymphocyte migration out of lymphatic tissues. Previous […]
Indian Businesses Lead AI ROI, Data Challenges
Indian businesses are showcasing the highest Return on Investment (ROI) from Artificial Intelligence (AI) implementations, but they also encounter significant data challenges. A study revealed that while 53 per cent of consumers receive personalized recommendations and offers, 77 per cent desire such suggestions. The increasing acceptance of AI-powered assistants is evident, with 56 per cent […]
Robust Chronic Kidney Disease Pipeline: 75+ Key Pharma Companies Actively
Ziltivekimab, a proprietary anti-interleukin-6 ligand monoclonal antibody, targets residual inflammatory cardiovascular risk in advanced chronic kidney disease (CKD) patients. Developed as a therapy to reduce major cardiovascular adverse events in CKD patients with atherosclerotic cardiovascular disease (ASCVD) and inflammation. Patients with moderate to severe CKD, ASCVD, and inflammation face high cardiovascular event risks with no […]
Kuwait Joins Global Drug Regulators’ Network
Kuwait has officially become a member of the global drug regulators’ network, gaining access to specialized international working groups for evaluating modern pharmaceutical preparations. Participation in the program allows Kuwait to benefit from advanced expertise provided by leading global regulatory agencies, enabling the country to enhance its regulatory framework in alignment with the latest healthcare […]
Innovative Tri-Specific Antibodies for Cancer Immunotherapy
Purple Biotech announces their novel CAPTN-3 tri-specific antibody platform at EACR 2025. The company focuses on developing first-in-class therapies to overcome tumor immune evasion and drug resistance. Their oncology pipeline includes CM24, a humanized monoclonal antibody that blocks CEACAM1 to target multiple cancer indications. NT219, a dual inhibitor small molecule, demonstrated anti-tumor activity in a […]
Rina-S Shows 50% Response Rate for Advanced Endometrial Cancer
In a study on advanced endometrial cancer, patients were administered either 100 mg/m2 (22 patients) or 120 mg/m2 (42 patients) of Rina-S. The confirmed overall response rate was 50% in the 100 mg/m2 group, with two complete responses. For the 120 mg/m2 group, the confirmed response rate was 47.1%, indicating anti-tumor activity. The median duration […]
Sandoz Introduces Pyzchiva Autoinjector for European Patients
Sandoz has launched the Pyzchiva autoinjector in Europe, offering patients a solution for managing chronic inflammatory diseases. Christophe Delenta, president Europe at Sandoz, emphasizes the importance of patient access to medicine beyond delivery. The autoinjector’s advanced features cater to real-world patient needs, showcasing Sandoz’s commitment to providing innovative solutions in the evolving European healthcare landscape. […]
Ascentage Pharma Unveils Alrizomadlin Clinical Data at ASCO 2025
Ascentage Pharma, a leading biopharmaceutical company, has presented encouraging clinical data on the MDM2-p53 inhibitor alrizomadlin (APG-115) at the 61st ASCO Annual Meeting. This Phase II study evaluated the efficacy of alrizomadlin as a monotherapy or in combination with the PD-1 inhibitor toripalimab in patients with advanced adenoid cystic carcinoma (ACC) and other solid tumors. […]
Revolutionizing Precision Oncology with Imagene’s AI Suite
Imagene’s OI Suite, powered by AI, utilizes CanvOI trained on 1.5M tissue samples to offer pharmaceutical companies an independent tool for hypothesis exploration. This versatile solution democratizes access to advanced AI tools, empowering translational research and clinical development teams to innovate and enrich their data. Whether cloud-based or on-premises, OI Suite eliminates the need for […]
AI-Driven Target Identification in Early Drug Discovery Collaboration
The collaboration between Axxam and Molecular Health focuses on integrating Molecular Health’s Dataome platform with Axxam’s DiscoveryMAXX workflow. Dataome utilizes artificial intelligence to analyze clinical, phenotypic, and molecular datasets, identifying disease-linked targets for potential therapeutics. Axxam then validates these leads using advanced in-vitro systems, including stem cell-based models that mimic human disease biology. This partnership […]
Revolutionizing Medicine with AI-Driven Biomarker Discovery
Predictive Oncology Inc. is at the forefront of revolutionizing medicine through AI-driven biomarker and drug discovery for precision health. With a vast biobank of diverse live-cell tumor specimens, the company is uniquely positioned to drive long-term value and shape the future of cancer treatment and drug development. Collaborating with UPMC Magee-Womens Hospital, Predictive Oncology developed […]
Enhancing Bioprinting and Advanced Manufacturing
The partnership between the DEVCOM Chemical Biological Center and the University of Hawaii aims to improve bioprinting and advanced manufacturing techniques. The DEVCOM Chemical Biological Center plays a crucial role in developing technologies to protect the military from chemical and biological threats, utilizing a team of experts across multiple sites in the United States for […]
Enhancing Bioprinting and Manufacturing: Army Lab and UH Partnership
The DEVCOM Chemical Biological Center collaborates with the University of Hawaii to improve bioprinting and advanced manufacturing capabilities. This partnership aims to enhance the development and application of technologies for protecting the military from chemical and biological threats. With a dedicated team of experts across multiple sites in the U.S., the Center focuses on research, […]
Revolutionizing Precision Oncology with Imagene’s AI Suite
Imagene’s OI Suite, powered by AI, utilizes CanvOI trained on 1.5M tissue samples to offer pharmaceutical companies an independent tool for hypothesis exploration. This versatile solution democratizes access to advanced AI tools, empowering translational research and clinical development teams to innovate and enrich their data. Whether cloud-based or on-premises, OI Suite eliminates the need for […]
AI-Driven Target Identification in Early Drug Discovery Collaboration
The collaboration between Axxam and Molecular Health focuses on integrating Molecular Health’s Dataome platform with Axxam’s DiscoveryMAXX workflow. Dataome utilizes artificial intelligence to analyze clinical, phenotypic, and molecular datasets, identifying disease-linked targets for potential therapeutics. Axxam then validates these leads using advanced in-vitro systems, including stem cell-based models that mimic human disease biology. This partnership […]
Revolutionizing Medicine with AI-Driven Biomarker Discovery
Predictive Oncology Inc. is at the forefront of revolutionizing medicine through AI-driven biomarker and drug discovery for precision health. With a vast biobank of diverse live-cell tumor specimens, the company is uniquely positioned to drive long-term value and shape the future of cancer treatment and drug development. Collaborating with UPMC Magee-Womens Hospital, Predictive Oncology developed […]
Enhancing Bioprinting and Advanced Manufacturing
The partnership between the DEVCOM Chemical Biological Center and the University of Hawaii aims to improve bioprinting and advanced manufacturing techniques. The DEVCOM Chemical Biological Center plays a crucial role in developing technologies to protect the military from chemical and biological threats, utilizing a team of experts across multiple sites in the United States for […]
Enhancing Bioprinting and Manufacturing: Army Lab and UH Partnership
The DEVCOM Chemical Biological Center collaborates with the University of Hawaii to improve bioprinting and advanced manufacturing capabilities. This partnership aims to enhance the development and application of technologies for protecting the military from chemical and biological threats. With a dedicated team of experts across multiple sites in the U.S., the Center focuses on research, […]
Sarvodaya Hospital Introduces Terbium-161 PSMA Therapy for Prostate Cancer
Sarvodaya Hospital in Faridabad has become India’s first Theranostics Center to offer Terbium-161 PSMA therapy for advanced prostate cancer patients. In addition to this groundbreaking therapy, the hospital now provides CAR-T Cell therapy, an advanced treatment for blood cancers like leukemia, lymphoma, and multiple myeloma, making it a one-stop destination for comprehensive cancer care. Dr. […]
Comprehensive Genomics Certification Program
A new certification program aligns with the National Health Service (NHS) curriculum in England, offering in-depth training in genomics. Key focus areas include Genetic Testing, Bioinformatics, Genomic Medicine, Cancer Genomics, and Genetic Counselling. The program features hands-on training by experts, English language support, and interview preparation for UK healthcare roles. This advanced certification in genomics […]
Vivodyne’s $40M Boost for Animal Testing Alternatives
Vivodyne, a biotech company, has secured $40 million in funding to further their research on animal testing alternatives. Led by Huh and Georgescu, their innovative system merges robotics and AI to enhance preclinical drug development, aiming to revolutionize the field. This investment signifies a significant step towards more ethical and effective testing methods in biotechnology, […]
Global Electroceuticals Market Trends and Technologies
Electroceuticals, also known as bioelectric medicine, offer an alternative to drug-based remedies and are used in treating various ailments through neurostimulation. The global electroceuticals market is projected to grow significantly due to factors like rising chronic disease prevalence, increased investment in advanced devices, and government support. Major players like GSK PLC and Microsoft Corp. have […]
EGFR Inhibitor Efficacy in Lung Cancer Brain Metastases
TYK Medicines’ EGFR inhibitor demonstrates promising results in lung cancer patients with brain metastases. Tagrisso and asandeutertinib have shown activity in EGFR-mutated NSCLC with central nervous system metastases. In the Phase III FLAURA 1 trial, patients on Tagrisso had a median progression-free survival of 15.2 months, outperforming standard therapy with another EGFR inhibitor. Additionally, the […]
Innovating Cell Therapy QC Testing
Advanced Therapy Medicinal Products have transformed treatment for severe diseases, but ensuring their safety pre-administration remains a challenge. Traditional Mycoplasma testing methods can cause delays, especially with high cell density and nucleic acid loads complicating QC workflows. Faster, validated methods are urgently needed to meet regulatory demands without sacrificing accuracy. With the demand for cell […]
Pharmaceutical Lab Equipment Market Growth Fueled by R&D and Biopharma
Research institutions are key players in the pharmaceutical lab equipment market, driving demand for high-precision tools essential for drug discovery and formulation. Government funding and academic collaborations enable investments in cutting-edge technologies, fostering innovation and the need for state-of-the-art lab equipment like microplate readers and HPLC systems. Shared facilities between universities and pharma companies enhance […]
Novel CAR-T Cell Therapy Delays Glioblastoma Tumor Progression
A groundbreaking Phase I trial showcased the efficacy of a dual-target CAR-T cell therapy in slowing the progression of glioblastoma tumors. Notable outcomes included several patients achieving a survival of 12 months or longer, a significant improvement compared to the typical prognosis of less than a year for this patient cohort. Encouragingly, two patients exhibited […]
Promising Results of CAR T Cell Therapy for Tough Tumours
A recent trial involving 156 participants with advanced gastric or gastro-oesophageal junction cancer, resistant to previous treatments, showed positive outcomes with Satri-cel. This cell therapy, administered up to 3 times alongside immune cell depletion, demonstrated efficacy in individuals positive for CLDN18.2. The control group received standard therapies like nivolumab, paclitaxel, or rivoceranib. Read more from […]
FDA Launches New AI Tool ‘Elsa’
The FDA has embraced artificial intelligence by launching a new AI tool named ‘Elsa.’ Built on Amazon Web Services’ GovCloud, Elsa securely handles sensitive government data without using proprietary manufacturer information. The tool was launched ahead of schedule and under budget, showcasing strong collaboration within the FDA. Elsa is already in use and is expected […]
Revolutionary Acquisition: STEMCELL Technologies and Cellular Highways Join Forces
STEMCELL Technologies, Canada’s leading biotechnology company, has acquired Cellular Highways Ltd, a UK-based biotech company specializing in advanced cell sorting technologies for cell and gene therapy, drug discovery, and general cell research. The acquisition includes the innovative Highway1 instrument, featuring Cellular Highways’ VACS™ technology, which enhances cell processing efficiency and maintains high cell integrity, reducing […]
Revolutionary Acquisition: STEMCELL Technologies and Cellular Highways Join Forces
STEMCELL Technologies, Canada’s leading biotechnology company, has acquired Cellular Highways Ltd, a UK-based biotech company specializing in advanced cell sorting technologies for cell and gene therapy, drug discovery, and general cell research. The acquisition includes the innovative Highway1 instrument, featuring Cellular Highways’ VACS™ technology, which enhances cell processing efficiency and maintains high cell integrity, reducing […]
Revolutionizing Cancer Care: Digital Tumors in Precision Oncology
Researchers at University of California San Diego have received a $23.6 million award from ARPA-H to develop a groundbreaking approach for selecting cancer treatments. The project, titled ‘Dynamic Digital Tumors for Precision Oncology,’ aims to transform cancer care with AI-powered tools that predict therapy outcomes and tumor evolution. These Drug Recommender Engines (DREs) will enhance […]
STX-001 mRNA Therapeutics Shows Promise in Treating Advanced Solid Tumors
In a groundbreaking development, Strand Therapeutics has revealed the initial Phase 1 data for STX-001 in patients with advanced solid tumors. This mRNA therapeutic aims to address the urgent need for new treatment options in patients who are resistant to immune checkpoint inhibitors. By delivering localized IL-12 expression to activate the tumor microenvironment and stimulate […]
Revolutionizing Pharma with AI, ML & Digital Twins in 2025
The convergence of artificial intelligence (AI), machine learning (ML), and digital twins is reshaping the pharmaceutical industry in 2025. With digital technologies transforming every aspect of the pharmaceutical value chain, from research and development to manufacturing and supply chain management, companies like Boehringer Ingelheim BioXcellence are at the forefront of this innovation. By leveraging advanced […]
Advanced Bioprocessing Technologies for Precision Coating Systems
In a dynamic industry where precision is paramount, KDF Technologies is leading the way with their cutting-edge batch in-line sputtering systems. These systems are not only advanced and reliable but also come at the industry’s lowest cost of ownership. Tailored to meet specific customer needs, KDF’s vacuum coating systems are integral in the production of […]
